Why EatLittle™

Weight control and treatments for obesity have been the subjects of a large amount of suggested diets, methods and procedures, including, in the most severe cases of morbid obesity, device implantations and/or direct surgical interventions.

In addition to EatLittle™, four other major streams of commercial products are currently available for the treatment of obesity.

The advantages of EatLittle™ over these technologies are discussed below.

Dietary regimens, and diet-related supplements and treatments

Currently, there is a large number of diets, dietary supplements, dietary regimens, and combinations thereof, and their number is constantly growing (Malik V.S. et al., 2007 *1). However, in the majority of cases, these weight loss strategies do not work, or their success is very limited. The success of these techniques often varies widely between individuals, and they are often not sustainable beyond their first year (Dubnov-Raz et al.,2008 *2), with the blame for the lack of success routinely put on you.

EatLittle™ offers:

An alternative, or a complimentary addition, to any diet

In the majority of cases, weight loss diets are accompanied by unpleasant, annoying and even irresistible feeling of hunger. EatLittle™ can replace or substantially improve any such diet. EatLittle™ is best administered concurrently with a Low Sodium Diet.

Reliable support in the starting period of any diet

The first days of any diet are very tough when hunger is very strong. EatLittle™ can ease this period without complications.

Support for significantly lower meal portions

For any chosen dietary regimen based on increased metabolism and hunger suppression. EatLittle™ helps you adapt to a new routine based on regular daily meals with much lower meal portions.

Successful body weight reduction sustainable for a long time period

Regular use of EatLittle™ will help maintain the achieved weight loss for a substantial time period. Moreover, after more than 3 months of regular EatLittle™ intake, it can be expected that the newly acquired alternative eating habits involving regular meals with reduced meal portions, will take firm roots.

Pharmacological Treatment using Specifically Developed Medications

After numerous attempts to introduce various anti-obesity drugs to the US and the EU markets, presently only two medications remain approved for sales in the USA, Orlistat (Xenical, Roche Laboratories, Nutley, NJ, USA), and Sibutramine (Meridia, Abbott Laboratories, Abbott Park, IL, USA). Drugs like Accomplia, Rimonabant, Phenytoin, and Phenolphthalein, have been banned from sale in the US and in Europe. There are calls for a ban of the controversial weight loss drug Alli being sold online. The range of side effects (Powers PS et al., 2008 *1, Fernstrom JD et al., 2008*2, Bray GA et al. 2007 *3) recently included potential liver damage for Xenical (Umemura T et al., 2005 *4) and from cardiovascular problems to suicidal tendencies and severe mood alterations for Meridia (Florentin EN et al., 2007 *5).

EatLittle™ presents an alternative anti-obesity treatment to any available drug, while excluding any possibility for drug-evoked side effects, some of which can be quite serious and life-threatening (Kolanowski J 1999 *6). Since the effect of EatLittle™ is non-pharmacological and purely mechanical, any risks to the liver and the brain associated with drug metabolism are eliminated.

Possibility for complete and controlled disintegration and expulsion

In case of discomfort, just purposefully drink hot beverages (min 45oC) and any remaining EatLittle™ pseudobezoars in the stomach will reduce their effectiveness and disintegrate. Hot water accelerates self-disintegration of the fiber “bites”. The constituent fibers from which EatLittle™ is built will leave the gastrointestinal tract in a non-obstructive and natural way.

You can completely control the amount of gastric volume reduction that you feel comfortable with, by daily intake between 1 to 4 capsules of EatLittle™ . Single capsules may be taken with two cups of water to create a sense of fullness to avoid snacking.

In contrast to bariatric surgery, EatLittle™ provides gastric volume reduction in a totally non-invasively way, only through an oral intake of a plain capsule, and without any surgical intervention. Thus, all adverse effects associated with bariatric surgery are eliminated.

Reversible and dynamically-controllable gastric volume reduction

Surgical modifications of gastrointestinal anatomy are either irreversible, or another surgery is needed to reverse these modifications. EatLittle™ can be taken at variable dosage, thus a dynamically controlling the amount of volume reduction. In addition, it can be disintegrated on demand by purposefully drinking hot beverages (min 45oC), thus ensuring a completely non-invasive reversal of its volume-reducing effects. Hot water accelerates self-disintegration of the fiber “bites”.

Positioning of the pseudobezoars in the lesser curvature of the stomach, rather than in the fundus

Clinical research indicates that EatLittle™ pseudobezoars position themselves in the area of the lesser curvature in the corpus or the proximal antrum of the stomach, which is dense of gastric mechanoreceptors.

Reduced cost for both- you, the customer, and the health system

Therapy based on EatLittle™ is of substantially lower cost than any bariatric surgery.

Full customer control

EatLittle™ is a dietary supplement and does not require the involvement of medical doctors, medical practitioners, dietologists, dietary centers and the like, as long as you follow the instructions on the label.

Intragastric Balloons or Bezoars

Intragastric balloons endoscopically positioned in the stomach to reduce the effective gastric volume have been found effective in inducing early satiety and a sensation of fullness, thus contributing to reduced food intake, which has been reliably related to sustainable weight loss (Dumonceau JM et al., 2008 *1 ). Although intragastric balloons have shown to be effective in addressing the problem of obesity, they remain invasive and can be associated with serious, and sometimes, life-threatening side effects (Cubattoli L et al., 2009 *2; Ruiz D et al., 2009 *3; Koutelidakis I, et al., 2009 *4) .

EatLittle™ offers:

Complete non-invasive administration and removal

In contrast with intragastric balloons, EatLittle™ is not endoscopically positioned but swallowable as a plain capsule. It is self-disintegratable, or can be disintegrated on demand in a faster way by purposefully drinking hot beverages (min 45oC).

100% biocompatibility

EatLittle™ is made of natural fibers and not of silicon like the invasively positioned, inflated and deflated intragastric balloons.

Permeability and lack of danger for intestinal obstruction

EatLittle™ is permeable to fluids and gases, and even if it reaches the intestines before completely disintegrating, it will ensure normal movement of physiological fluids and gases.

Easy maintenance and control by the consumer

You control the rhythm of EatLittle™ intake, the quantity of capsules per dose (without overdosing), and the removal of the pseudobezoars from your body without the need of medical assistance.